Copyright
©The Author(s) 2024.
World J Hepatol. Nov 27, 2024; 16(11): 1255-1264
Published online Nov 27, 2024. doi: 10.4254/wjh.v16.i11.1255
Published online Nov 27, 2024. doi: 10.4254/wjh.v16.i11.1255
Characteristics | Normal range | Total (n = 546) | Sepsis (n = 373) | SILI (n = 173) | P value |
Age, year, median (IQR) | - | 65 (51-81) | 66 (50.5-81.5) | 63 (51-76) | 0.166 |
Male, n (%) | - | 380 (69.6) | 258 (69.2) | 122 (70.5) | 0.749 |
WBC, × 109/L, median (IQR) | 3.5-9.5 | 11.0 (7.9-15.2) | 10.8 (7.7-14.6) | 12.1 (8.2-16.4) | 0.047 |
RBC, × 1012/L, mean ± SD | 3.8-5.1 | 3.4 ± 0.9 | 3.4 ± 0.9 | 3.5 ± 1.1 | 0.212 |
HGB, g/L, mean ± SD | 115-150 | 103.7 ± 28.9 | 103.3 ± 27.3 | 104.7 ± 32.0 | 0.624 |
Platelet, × 109/L, median (IQR) | 125-350 | 163.5 (109.8-230.3) | 172.0 (124.0-237.5) | 136.0 (73.0-215.5) | < 0.001 |
ALT, U/L, median (IQR) | 0-40 | 26.8 (14.2-60.7) | 18.6 (12.0-32.4) | 98.0 (42.4-217.7) | < 0.001 |
AST, U/L, median (IQR) | 8-40 | 37.3 (20.9-75.1) | 27.1 (18.7-42.8) | 116.8 (74.6-333.2) | < 0.001 |
TBIL, mmol/L, median (IQR) | 3.42-20.5 | 13.3 (7.8-24.4) | 10.4 (6.8-16.4) | 35.0 (14.7-63.4) | < 0.001 |
Albumin, g/L, mean ± SD | 38-51 | 31.9 ± 6.8 | 33.0 ± 6.6 | 29.4 ± 6.6 | < 0.001 |
Cr, mmol/L, median (IQR) | 44-80 | 84.2 (59.9-152.0) | 76.1 (56.0-118.8) | 110.1 (73.4-193.8) | < 0.001 |
CRP, mg/L, median (IQR) | 0-5 | 41.2 (8.5-100.2) | 34.1 (8.3-85.6) | 53.9 (11.2-117.8) | 0.003 |
Lac, mmol/L, median (IQR) | 0.5-1.6 | 1.7 (1.0-3.6) | 1.4 (0.9-2.7) | 3.2 (1.7-5.5) | < 0.001 |
PT, s, median (IQR) | 10-14 | 14.3 (12.9-16.4) | 13.9 (12.7-15.4) | 15.4 (13.6-19.6) | < 0.001 |
APTT, s, median (IQR) | 22-38 | 31.2 (26.8-36.9) | 30.4 (26.6-35.4) | 33.5 (27.7-41.5) | < 0.001 |
FIB, g/L, median (IQR) | 2-4.5 | 2.7 (1.8-3.5) | 2.8 (2.0-3.6) | 2.3 (1.5-3.3) | < 0.001 |
TT, s, median (IQR) | 10-16 | 16.1 (14.7-17.9) | 15.7 (14.5-17.4) | 17.4 (15.2-19.6) | < 0.001 |
FDP, mg/L, median (IQR) | 0-5 | 7.5 (3.1-19.3) | 5.9 (2.5-14.6) | 13.0 (5.5-31.8) | < 0.001 |
D-dimer, mg/L, median (IQR) | 0-0.5 | 2.5 (1.0-6.1) | 2.0 (0.8-4.8) | 4.2 (1.7-9.4) | < 0.001 |
TM, TU/mL, median (IQR) | 3.82-13.35 | 10.8 (7.7-16.9) | 10.0 (7.3-14.5) | 13.3 (9.3-23.1) | < 0.001 |
TAT, ng/mL, median (IQR) | 0-4.07 | 10.1 (4.6-29.1) | 7.5 (4.0-20.4) | 18.4 (7.5-53.3) | < 0.001 |
t-PAIC, ng/mL, median (IQR) | Female: 0-10.5. Male: 0-17.0 | 12.2 (7.4-18.9) | 9.8 (5.9-14.4) | 20.6 (14.9-29.9) | < 0.001 |
PIC, μg/mL, median (IQR) | 0-0.85 | 1.3 (0.7-2.4) | 1.2 (0.7-2.1) | 1.6 (0.7-3.3) | 0.021 |
GCS score, median (IQR) | 15 | 8 (4-12) | 9 (5-12) | 7 (3-12) | 0.032 |
APACHE II score, median (IQR) | 0 | 21 (16-27) | 20 (16-26) | 23 (18-28) | 0.001 |
Child-Pugh score, median (IQR) | 5 | 8 (7-9) | 7 (7-8) | 9 (8-11) | < 0.001 |
- Citation: Zhou Y, He LP, Qi YH, Huang Y, Hu BQ, Liu JL, Zeng QB, Song JC. Diagnostic value of tissue plasminogen activator-inhibitor complex in sepsis-induced liver injury: A single-center retrospective case-control study. World J Hepatol 2024; 16(11): 1255-1264
- URL: https://www.wjgnet.com/1948-5182/full/v16/i11/1255.htm
- DOI: https://dx.doi.org/10.4254/wjh.v16.i11.1255